Sun, 21 Jul 2024

 

Fidson Healthcare introduces new drug to address sexual dysfunction
 
By:
Thu, 14 Nov 2013   ||   Nigeria,
 

Concerned about the challenge of about 43.8 to 57.4 percent of Nigerian men over 35 years of age reportedly affected by sexual dysfunction, Fidson Healthcare Plc has taken a bold step in addressing this growing challenge with the introduction of its new product, Vigomax Forte.

According to Ola Ijimakin, General Manager, Marketing, Fidson Healthcare Plc,  “The introduction of Vigomax is another demonstration of Fidson’s innovative approach to ensuring the quality lifestyle and healthy living for Nigerians, as the company continues to make a bold statement of its corporate value proposition, which is ‘…..we value life’.

“Vigomax Forte is a rational Aphrodisiac formulation that combines time tested efficacious herbs, which are known to increase the sexual desire, correct weak erection and enhances libido in men. It increases sexual urge and intra cavernous pressure due to androgen increasing property by releasing bound testosterones, offers testosterone like-effect as well as enhances vigor and vitality,” Ijimakin explained.

Mr. Ijimakin who described the rate of sexual dysfunction amongst Nigerian men as worrisome also expressed concern over its effect on the sexual health, as well as emotional, social and psychological wellbeing of Nigerian families and homes.

Stating that sexual dysfunction has resulted in the breakup of many marriages and caused serious problems in many homes in Nigeria, he added that Vigomax has brought hope to affected couples.

The unveiling of this new product is coming at a time as shareholders of Fidson Healthcare Plc approved a dividend of 12 kobo per share recommended by the company’s board for the year ended December 31, 2012.

 

Tag(s):
 
 
Back to News